HSR24-154: Real-World Clinical Outcomes in Patients With Advanced/Metastatic Melanoma and Brain Metastases Treated With Pembrolizumab Monotherapy—An Analysis of the ADOReg German Skin Cancer Registry

Authors:
Ruixuan Jiang Merck & Co., Inc., Rahway, NJ, USA

Search for other papers by Ruixuan Jiang in
Current site
Google Scholar
PubMed
Close
 PharmD, PhD
,
Michael Weichenthal University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

Search for other papers by Michael Weichenthal in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Cesar I. Fernandez-Lazaro IQVIA, Madrid, Spain

Search for other papers by Cesar I. Fernandez-Lazaro in
Current site
Google Scholar
PubMed
Close
 PhD, MPH, PharmD
,
Anja Rudolph IQVIA, 60549 Frankfurt, Germany

Search for other papers by Anja Rudolph in
Current site
Google Scholar
PubMed
Close
 MSc, PhD
,
Clemens Krepler Merck & Co., Inc., Rahway, NJ, USA

Search for other papers by Clemens Krepler in
Current site
Google Scholar
PubMed
Close
 MD
,
Peter Mohr DElbe Kliniken Buxtehude, Buxtehude, Germany

Search for other papers by Peter Mohr in
Current site
Google Scholar
PubMed
Close
 MD, PhD
, and
on behalf of the ADOReg investigators
Search for other papers by on behalf of the ADOReg investigators in
Current site
Google Scholar
PubMed
Close
on behalf of the ADOReg investigators
Restricted access

Corresponding Author: Ruixuan Jiang, PharmD, PhD
  • Collapse
  • Expand
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 266 266 27
PDF Downloads 128 128 0
EPUB Downloads 0 0 0